Full video transcriptClick to expand
Auto-generated transcript of @romina.iranmanesh's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Let's reconstitute Retta.
- 0:01I'm using a 10 milligram vial.
- 0:02They'll also need Haspira brand backwater,
- 0:05some alcohol wipes, and some of these.
- 0:07Make sure your hands are clean.
- 0:08Really rub the top of it.
- 0:11For every 10 milligrams, I add a one milliliter of backwater.
- 0:15If you have a 20 milligram vial,
- 0:16you would add two milliliters of backwater.
- 0:18If you follow that dilution,
- 0:19every 10 units is gonna be a one milligram dose.
- 0:23Just put the needle in there, flip it around.
- 0:25Then you're gonna pull 100 units.
- 0:27Flip it around.
- 0:28You're gonna take your vial and just poke it in.
- 0:31Very slowly inject the liquid.
- 0:35You can roll it like this to mix.
- 0:36Let this sit for about 30 minutes
- 0:38until everything's dissolved.
- 0:39It's ready for your lab rat.
GHK-Cu peptide claims: separating real data from hype
Quick answer
GHK-Cu is a copper-binding tripeptide with preclinical evidence for wound healing and collagen synthesis, primarily studied in vitro and in animal models. The reconstitution method shown (bacteriostatic water, 1mL per 10mg) is pharmacologically standard but omits critical storage and sterility guidance relevant to home handling. No injectable GHK-Cu product is FDA-approved or has completed Phase III human clinical trials as of 2024.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
GHK-Cu (Copper Peptide) access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 4 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For GHK-Cu peptide claims: separating real data from hype, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
GHK-Cu (Copper Peptide) is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this ghk-cu video claims cluster
Best for searchers checking whether GHK-Cu beauty and recovery claims match the evidence base.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "GHK-Cu peptide claims: separating real data from hype" from Romina Iranmanesh. We read the clip as a Peptide social video fact-checks claim about GHK-Cu (Copper Peptide), then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: GHK-Cu is a copper-binding tripeptide with preclinical evidence for wound healing and collagen synthesis, primarily studied in vitro and in animal models.
The reason this review is not generic is the source wording and the canonical claim label "peptides how to reconstitute ratatouille for your lab rat this is not." In this clip, the useful excerpt is: "Let's reconstitute Retta." That wording changes the review because it points to GHK-Cu (Copper Peptide) safety, access, evidence, and fit, not a one-size-fits-all protocol.
The source trail for this page is checked against The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging (2015), Effects of glycyl-histidyl-lysine-Cu on wound healing (Search), and Copper peptide and skin remodeling literature (Search), plus the creator's own wording. GHK-Cu (Copper Peptide) still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
GHK-Cu is a copper-binding tripeptide with preclinical evidence for wound healing and collagen synthesis, primarily studied in vitro and in animal models.
FormBlends verdict
GHK-Cu (Copper Peptide) safety, access, evidence, and fit
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with the GHK-Cu (Copper Peptide) guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- GHK-Cu is a copper-binding tripeptide with preclinical evidence for wound healing and collagen synthesis, primarily studied in vitro and in animal models. The reconstitution method shown (bacteriostatic water, 1mL per 10mg) is pharmacologically standard but omits critical storage and sterility guidance relevant to home handling. No injectable GHK-Cu product is FDA-approved or has completed Phase III human clinical trials as of 2024.
- The 1mL per 10mg dilution ratio is mathematically correct and produces a 10mg/mL solution where 10 units on a U-100 syringe equals 1mg.
- Bacteriostatic water is the appropriate solvent for GHK-Cu reconstitution; it inhibits bacterial growth and typically preserves the solution for 28 to 30 days when refrigerated.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- GHK-Cu (Copper Peptide) decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the GHK-Cu (Copper Peptide) guide, cost path, safety notes, and provider review before acting.
Review GHK-Cu (Copper Peptide)What You'll Learn
- The 1mL per 10mg dilution ratio is mathematically correct and produces a 10mg/mL solution where 10 units on a U-100 syringe equals 1mg.
- Bacteriostatic water is the appropriate solvent for GHK-Cu reconstitution; it inhibits bacterial growth and typically preserves the solution for 28 to 30 days when refrigerated.
- Most GHK-Cu human evidence comes from topical applications. Injectable use in humans lacks Phase III clinical trial data as of 2024.
- Pickart and Margolina (2018, Biomolecules) documented broad preclinical activity for GHK-Cu, but the review is largely based on cell culture and animal studies, not human injection trials.
- Cohen et al. (2021, JAMA Internal Medicine) found that unregulated peptide products commonly deviate from labeled concentrations, meaning a research-grade vial may not contain what it claims.
- The video does not address post-reconstitution storage, vial puncture expiration, or environmental sterility, all of which affect safety in home handling.
- The 'lab rat' disclaimer is a legal convention in peptide content, not evidence that viewers are not using this guidance on themselves.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @romina.iranmanesh actually say?
She walked through how to reconstitute a 10mg vial of GHK-Cu (which she calls "Retta") using bacteriostatic water, alcohol wipes, and an insulin syringe. Her core instruction: add 1mL of bacteriostatic water per 10mg of peptide, which she says makes "every 10 units a one milligram dose." She demonstrated needle insertion, slow injection into the vial, and suggested rolling the vial to mix before letting it sit about 30 minutes. The whole thing is framed as being for a "lab rat," a well-known workaround in peptide communities to avoid direct medical advice disclaimers.
The video is explicit that GHK-Cu is not approved for human use, which is accurate. It stops short of telling viewers what to actually do with the reconstituted vial once it is ready for the "rat." But the production quality, the step-by-step format, and the 56,000 views make the intended audience pretty obvious.
Does the science back this up?
The reconstitution math is correct. The "lab rat" framing does not change that. GHK-Cu (glycine-histidine-lysine-copper) is a naturally occurring copper peptide with a real and reasonably well-studied research profile, mostly in cell culture and animal models. The evidence for human therapeutic use is far thinner than peptide communities typically acknowledge.
GHK-Cu has shown activity in promoting wound healing, stimulating collagen synthesis, and modulating inflammation in preclinical settings. Pickart and Margolina (2018, in Biomolecules) reviewed the peptide's broad biological activity, including effects on gene expression related to skin repair and anti-inflammatory pathways. However, the bulk of this research is in vitro or in animal models. Controlled human clinical trials are limited and mostly confined to topical cosmetic applications, not injectable protocols. The jump from "interesting cell biology" to "inject this into yourself" is not one the published literature makes cleanly.
Bacteriostatic water is the appropriate solvent here. That part she got right.
What did they get wrong (or right)?
The dilution ratio and the resulting concentration math are accurate. One milliliter of bacteriostatic water per 10mg gives a concentration of 10mg/mL, and on a U-100 insulin syringe, 10 units equals 0.1mL, which works out to 1mg. The arithmetic checks out.
What she glosses over: sterile technique in this video is incomplete. Wiping the vial top is mentioned, but there is no discussion of working in a clean environment, the risk of contamination during reconstitution, or how to handle the vial once punctured. Bacteriostatic water contains benzyl alcohol, which inhibits bacterial growth and extends the usable life of a reconstituted peptide, typically 28 to 30 days refrigerated. She does not mention storage or expiration after reconstitution, which matters a lot for anyone handling a peptide at home.
She correctly states GHK-Cu is not approved for human use. That disclaimer is accurate and legally necessary. But the "lab rat" framing is a fig leaf, not a firewall. Posting a step-by-step injection prep tutorial on TikTok to 56,000 viewers is, by any reasonable reading, instructing people on how to use this compound themselves.
What should you actually know?
GHK-Cu is not a dangerous fringe compound in the way some research peptides are, but that does not mean self-injection is low-risk or well-supported. The peptide's safety profile in injectable form for humans has not been established through rigorous clinical trials. The most studied and supported delivery route for GHK-Cu in humans is topical, not subcutaneous or intravenous.
Anyone reconstituting injectable peptides at home is taking on real risks: contamination, dosing errors, unknown purity of research-grade compounds, and zero medical oversight if something goes wrong. Research peptides sold online are not manufactured under FDA current Good Manufacturing Practice (cGMP) standards. A 2021 analysis by Cohen et al. (JAMA Internal Medicine) found that unregulated peptide products frequently deviate from labeled concentration. The vial might not contain what the label says.
If you are interested in GHK-Cu for wound healing, collagen support, or skin health, topical formulations are the only human-use application with any meaningful clinical backing. Any injectable use sits firmly in experimental territory, regardless of how confident a TikTok tutorial sounds.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Romina Iranmanesh · TikTok creator
56.1K views on this video
How to reconstitute ratatouille for your lab rat. This is not medical advice, this is for entertainment purposes only. This peptide is not yet approved for human use. #ratatouille #ghkcu #peppers #collagen
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about the 1ml per 10mg dilution ratio?
The 1mL per 10mg dilution ratio is mathematically correct and produces a 10mg/mL solution where 10 units on a U-100 syringe equals 1mg.
What does the video say about bacteriostatic water?
Bacteriostatic water is the appropriate solvent for GHK-Cu reconstitution; it inhibits bacterial growth and typically preserves the solution for 28 to 30 days when refrigerated.
What does the video say about most ghk-cu human evidence comes from topical applications. injectable use?
Most GHK-Cu human evidence comes from topical applications. Injectable use in humans lacks Phase III clinical trial data as of 2024.
What does the video say about pickart?
Pickart and Margolina (2018, Biomolecules) documented broad preclinical activity for GHK-Cu, but the review is largely based on cell culture and animal studies, not human injection trials.
What does the video say about cohen et al. (2021, jama internal medicine) found?
Cohen et al. (2021, JAMA Internal Medicine) found that unregulated peptide products commonly deviate from labeled concentrations, meaning a research-grade vial may not contain what it claims.
What does the video say about the video does not address post-reconstitution storage, vial puncture expiration,?
The video does not address post-reconstitution storage, vial puncture expiration, or environmental sterility, all of which affect safety in home handling.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Romina Iranmanesh, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.